AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Advancements in Connective Tissue Disease Treatments
This chapter examines the complexities of treating cutaneous lupus erythematosus and dermatomyositis, focusing on cytokine profiles and the potential of JAK inhibitors. It also reviews recent clinical trial findings, including the efficacy of Ducravacitinib and lenabazine, while addressing challenges in approving treatments for rare autoimmune diseases.